Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Direxion NASDAQ 100 Equal Weighted Index Shares (QQQE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Direxion NASDAQ 100 Equal Weighted Index Shares — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.74B), while Direxion NASDAQ 100 Equal Weighted Index Shares trades at $121.58 (market cap $1.45B). The key difference: Nuvation Bio Inc. Class A Common Stock is the larger of the two by market cap, and Direxion NASDAQ 100 Equal Weighted Index Shares is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Direxion NASDAQ 100 Equal Weighted Index Shares for 47 Days on average.
| NUVB | QQQE | |
|---|---|---|
Market Cap | $1.74B | $1.45B |
Volume | 9,289,619 | 323,568 |
Sector | Health | Broad Market / Factor |
52-Week High | $9.54 | $124.69 |
52-Week Low | $3.41 | $96.06 |
Typical Hold Time | 0 Days | 47 Days |
Enterprise Value | $1.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQE trades at $121.89, down 0.89% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF provides equal-weighted exposure to NASDAQ-100 large-cap growth stocks, reducing technology concentration compared to market-cap weighted alternatives. Recent analysis highlights QQQE's tactical appeal for diversification within tech-heavy indices.
The equal-weight methodology offers fundamental diversification benefits, though specific financial ratios are unavailable for the ETF structure. Market sentiment appears constructive with technical strength, but investors face typical ETF risks including market volatility and sector concentration despite the equal-weight approach.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Direxion NASDAQ 100 Equal Weighted Index Shares
QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →
